EMEA-001135-PIP01-11
Key facts
Invented name |
Forsteo
|
Active substance |
teriparatide
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/189/2011
|
PIP number |
EMEA-001135-PIP01-11
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
|
Route(s) of administration |
|
Contact for public enquiries |
Eli Lilly & Company Limited
E-mail: eu_paediatric@lilly.com |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|